Switching from Donepezil or Rivastigmine to Galantamine in Clinical Practice
Author:
Publisher
Wiley
Subject
Geriatrics and Gerontology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1532-5415.2004.52529_3.x/fullpdf
Reference5 articles.
1. Use of cholinesterase inhibitors in clinical practice;Cummings;Evidence-based recommendations,2003
2. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors;Samochocki;J Pharmacol Exp Ther,2003
3. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease;Jones;Psychopharmacology (Berl),1992
4. Strategies for continued successful treatment of Alzheimer's disease;Gauthier;Switching cholinesterase inhibitors,2003
5. Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease;Doody;Arch Neurol,2001
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Strategies for Continued Successful Treatment in Patients with Alzheimer’s Disease: An Overview of Switching Between Pharmacological Agents;Current Alzheimer Research;2018-08-15
2. Therapeutic effects of drug switching between acetylcholinesterase inhibitors in patients with Alzheimer's disease;Geriatrics & Gerontology International;2017-01-06
3. Predicting the neural effect of switching from donepezil to galantamine based on single-photon emission computed tomography findings in patients with Alzheimer's disease;Psychogeriatrics;2015-06-26
4. The Effects of an Uninterrupted Switch from Donepezil to Galantamine without Dose Titration on Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease;Dementia and Geriatric Cognitive Disorders Extra;2014-05-21
5. Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer’s disease receiving donepezil;Neuropsychiatric Disease and Treatment;2013-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3